Home ProductsPOCT Test Kit

NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette

NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette

  • NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette
  • NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette
  • NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette
NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette
Product Details:
Place of Origin: CN
Brand Name: WWHS
Certification: CE
Model Number: NSE
Payment & Shipping Terms:
Minimum Order Quantity: 1000
Price: US 1.50 - 2.50 Kit
Packaging Details: Colorful Paper Box
Delivery Time: 7 Days
Payment Terms: T/T
Supply Ability: 20000 Kits per Week
Contact Now
Detailed Product Description
Product Name: NSE Rapid Test Cassette Type: One Step Assay
Storage: At Room Temperature Package: 20T
Formal Name: Neuron Specific Enolase Reactivity: Human
Application In: WWHS NIR-1000 Dry Fluoroimmunoassay Analyser Manufacturer: WWHS Biotech INC
Usage: Tumor Marker Keywords: High Stability, High Sensitivity, High Accuracy

NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette

 

Neuron specific enolase (NSE) which can also be called gamma-enolase (ENO-2) or 2-phospho-D-glycerate hydrolase, is an isoenzyme belonging to the enolase family that consists up of α, β and γ subunits either has a homo or heterodimer. NSE is a 78 kD gamma-homodimer and the majority of this enolase-isoenzyme can be found in neuroendocrine and neuronal tissues. It is essentially a glycolytic enzyme that is able to catalyse the conversion of 2-phosphoglycerate into phosphoenolpyruvate. The biological half-life of neuron specific enolase in body fluids is about 24 hours and due to the organ-specificity and concentrations of NSE in serum or cerebrospinal fluid (CSF), elevated levels

have been identified in diseases which result in relative rapid neuronal destruction.

 

This is our new Revolutionary FIA, using Near IR technology however conventional UV light, the Sensitivity&Precision is Outstanding Excellent.
with broad range of test parameters developed by Sino-US PHD team.

 

We are open to discuss intl distributorship and partnership.

 

Importance of IVD

 

The importance of in vitro diagnosis in life and health is mainly reflected in that no matter healthy people, asymptomatic and symptomatic people and people with chronic diseases are inseparable from diagnostics, and diagnosis runs through the whole medical cycle. In particular, modern medicine has entered the era of precision medicine, and the core of precision medicine is accurate diagnosis.

 

Note:


1) Any variation in operator, pipetting and washing technique, incubation time or temperature, and kit age can cause variation in
result. Each user should obtain their own standard curve.

2) If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor.
3) If specimens generate values higher than the highest standard, dilute the specimens and repeat the assay

 

 

NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette 0NSE Rapid Quantitative Test Kit IFA IVD WWHS FIA POCT Assay Cassette 1

 

cat#. Product Item Specimen Reaction Time Measure Range Clinical Range Itended Use
Cardiac          
1 cTnI WB/Serum/Plasma 12min. 0.1-40ng/ml <0.3ng/ml several heart diseases including myocardial infarction and heart failure.
2 Myo WB/Serum/Plasma 12min. 5-400ng/ml <58ng/ml acute myocardial infarction (AMI) in early stage.
3 CK-MB WB/Serum/Plasma 12min. 1-200ng/ml <5ng/ml acute myocardial infarction (AMI) in early stage.
4 NT-proBNP WB/Serum/Plasma 10min. 20-35000pg/ml Under 75:0~347pg/mL,
Over 75:0~449pg/mL
heart failure .
5 D-Dimer WB/Plasma 10min. 40-10000ng/ml <500ng/ml disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6 cTnI+Myo+CKMB WB/Serum/Plasma 12min. same with single item same with single item Triple marker of myocardial infarction.
7 ST2 WB/Serum/Plasma 10min. 10-400ng/ml <35ng/ml heart failure .
8 Lp-PLA2 WB/Serum/Plasma 10min. 10-900ng/ml <175ng/ml Risk evaluation of ACS and atherosclerotic ischemic stroke patients.
9 S100-β WB/Serum/Plasma 10min. 0.05-10ng/ml <0.2ng/ml Cerebral infarction, cerebral injury.
Inflammation          
10 CRP / hs-CRP WB/Serum/Plasma 3min. 0.5-200mg/L CRP<10mg/L,hs-CRP<1mg/L nonspecficity inflammatory marker.
11 SAA Serum 5min. 1-200mg/L <10mg/L inflammation&infection.
12 PCT WB/Serum/Plasma 10min. 0.2-100ng/ml <0.5ng/ml Sepsis
13 CRP+SAA WB/Serum/Plasma 5min. same with single item same with single item inflammation&infection.
14 IL-6 WB/Serum/Plasma 10min. 5-4000pg/ml 10pg/ml diabetes,rheumatoid arthritis,etc
Thyroid Hormone          
15 TSH Serum/Plasma 15min. 0.3-100mU/L 0.35-5mU/L hyperthyroidism and hypothyroidism
16 TT3 Serum/Plasma 15min. 0.5-10nmol/L 1.3-3.1nmol/L thyroid dysfunction
17 TT4 Serum/Plasma 15min. 5-300nmol/L 66-181nmol/L thyroid dysfunction
18 FT3 Serum/Plasma 15min. 1-100pmol/L 4-10pmol/L thyroid dysfunction
19 FT4 Serum/Plasma 15min. 5-300pmol/L 19-39pmol/L thyroid dysfunction
Tumor Marker          
20 AFP Serum/Plasma 15min. 2.5-200ng/ml <20ng/ml pregnancy cancer
21 CEA Serum/Plasma 15min. 1-200ng/ml <5ng/ml colon cancer, colorectal cancer,etc.
22 NSE Serum/Plasma 15min. 1-400ng/ml <16ng/ml non-small cell lung cancer
23 FOB fecal specimens 10min. 50-1000ng/ml <100ng/ml Abnormal recessive gastrointestinal bleeding
24 PG II Serum/Plasma 15min. 1-100ug/L PGI/PGII>3.0 gastric abnormalities
25 PG I Serum/Plasma 15min. 2.5-200ug/L >70ng/ml gastric abnormalities
26 TPSA Serum/Plasma 15min. 0.5-40ng/ml <4ng/ml prostate cancer
27 FPSA Serum/Plasma 15min. 0.1-10ng/ml <1ng/ml prostate cancer
28 CA12-5 Serum/Plasma 15min. 20-500U/ml <35U/ml ovarian cancer
29 CA15-3 Serum/Plasma 15min. 10-400U/ml < 25 U/mL breast cancer
30 HE4 Serum/Plasma 15min. 50-2000pmol/L <140 pmol/L ovarian cancer
31 CA19-9 Serum/Plasma 15min. 10-400U/ml < 27 U/mL pancreatic cancer
32 β-HCG Serum/Plasma 15min. 5-400mIU/ml <10 mIU/mL Early pregrancy, ectopic HCG cancer,incomplete abortion
33 CK19(Cyfra21-1) Serum/Plasma 15min. 0.5-50ng/ml <2.5ng/ml non-small cell lung cancer
Fertility          
34 HCG / β-HCG Serum/Plasma 10min. 5-20000mIU/ml <5 mIU/mL early pregrancy.
35 AMH Serum/Plasma 10min. 0.1-16ng/ml Male: 20-60 years old, 0.92-13.89 ng/mL
Female: 20-29 years old, 0.88-10.35 ng/mL
30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
ovarian reserve level
36 LH Serum/Plasma 20min. 1-200mIU/ml Male: 1.70-8.60 mIU/mL;
Female:
Follicular phase : 2.95 13.65 mIU/mL
Ovulation phase: 13.65-95.75 Miu/mL Luteal phase: 1.25-11.00 mIU/mL
Menopause phase: 8.24 -55.23 mIU/mL
reproductive dysfunction
37 FSH Serum/Plasma 20min. 1-100mIU/ml Male: 1.50-12.40 mIU/mL
Female:
Follicular phase : 4.46-12.43 mIU/mL Ovulation phase: 4.88-20.96 mIU/mL Luteal phase: 1 .96-7.70 mIU/mL
Menopause phase: 22.70-130.00 mIU/mL
reproductive system
38 Testosterone Serum/Plasma 20min. 0.25-16ng/ml Male: 20-49 years old, 1.61-8.41 ng/mL
>50 years old, <0.61 ng/mL
Female: 20-49 years old, <0.80ng/mL
>50 years old, <0.71 ng/mL
sexual hormone disturbance and hypogonadism.
39 Progesterone Serum/Plasma 20min. 1-50ng/ml   pregrancy progesterone
40 PRL Serum/Plasma 20min. 1-200ng/ml Female (non-pregnant): 4.60-25.07 ng/mL Male: 3.45-17.42 ng/mL breastfeeding&abnormal lactation
41 SHBG Serum/Plasma 20min. 1-200nmol/L 15-120nmol/L unphysiological diseases.
42 E2 Serum/Plasma 20min. 10-1000pg/ml Male: <85 pg/mL
Female:
Follicular Phase: 12-262 pg/mL
Ovulation: 40-396 pg/mL
Luteal Phase: 21-381 pg/mL
Menopause: <190 pg/mL
Pregnancy: >145 pg/mL
ovarian vitality.
Gastrointestinal            
43 FOB fecal specimens 10min. qualitative qualitative gastrointestinal hemorrhage.
44 TRF fecal specimens 10min. qualitative qualitative gastrointestinal hemorrhage.
45 FOB+TRF fecal specimens 10min. qualitative qualitative gastrointestinal hemorrhage.
Infection            
46 Covid-19 Antigen nasal swab, throat swab or nasal wash/aspirate specimens 15min. qualitative qualitative respiratory tract
47 Covid-19 Ab IgG/IgM WB/Serum/Plasma 15min. qualitative qualitative respiratory tract
48 FluA nasal swab, throat swab or nasal wash/aspirate specimens 15min. qualitative qualitative respiratory tract
49 FluB nasal swab, throat swab or nasal wash/aspirate specimens 15min. qualitative qualitative respiratory tract
Renal injury            
50 CysC WB/Serum/Plasma 5min. 0.4-9mg/L 0.5-1.1mg/L renal function
51 NGAL Urine 10min. 10-1500ng/mL <132ng/mL acute kidney injury.
Other            
52 FERR Serum 5min. 10-500ng/ml Male:24ng/mL~335ng/mL,
Female:11ng/mL~307ng/mL
iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
53 HbA1c WB 10min. 4%-14% 4%-6% diabetes
54 VD Serum/Plasma 15min. 8-70ng/mL 19-57ng/mL fetation

 

 

Contact Details
WWHS Biotech.Inc(exclusive marketed by Dawin)

Contact Person: sales

Tel: +8613823276027

Send your inquiry directly to us (0 / 3000)

Contact

Address: Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen

Factory Address:Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen